| abstract |
The invention describes bicyclic heterocycles of the general formula (I) in which RR, AE and X have the meanings indicated in claim 1, their tautomers, their stereoisomers and their salts, especially their physiologically acceptable salts with inorganic or organic acids or bases . The proposed compounds possess valuable pharmacological properties, primarily the inhibitory effect on signal transduction mediated by tyrosine kinases, the invention describes their preparation and use for the treatment of various diseases, especially tumor diseases, lung and respiratory diseases. |